Effect of hydroxypropyl methylcellulose on obesity and glucose metabolism in a diet-induced obesity mouse model

Journal of Diabetes

Volumn 3, Issue 2, 2011, Pages 158-167

  Hung, Shao Ching ^a   Anderson, William H K ^a   Albers, David R ^a   Langhorst, Marsha L ^a   Young, Scott A ^a  

^a DOW CHEMICAL COMPANY   (United States)

Author keywords

Diabetes; Diet induced obesity; Hydroxypropyl methylcellulose (HPMC); Soluble dietary fiber

Indexed keywords

ADIPONECTIN; BILE ACID; CHOLESTEROL; FECES LIPID; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN; LEPTIN; STEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; LIPID ABSORPTION; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER WEIGHT; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIETARY FATS; INSULIN; LEPTIN; LIVER; MALE; METHYLCELLULOSE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; RANDOM ALLOCATION; REGRESSION ANALYSIS; WEIGHT LOSS;

EID: 79956205260     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2011.00118.x     Document Type: Article

References (33)

1. BeMiller JN, Whistler RL. Carbohydrates. In: Fennema OR (ed.). Food Chemistry, 3rd edn. Marcel Dekker, Inc., New York, 1996; 157-223.
2. Burdock GA. Safety assessment of hydroxypropylmethylcellulose as a food ingredient. Food Chem Toxicol. 2007; 45: 2341-51.
3. Maki KC, Carson ML, Miller MP et al. High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses. Diabetes Care. 2007; 30: 1039-43.
4. Lightowler HJ, Henry CJK. Glycemic response of mashed potato containing high-viscocity hydroxypropylmethylcellulose. Nutr Res. 2009; 29: 551-7.
5. Maki KC, Carson ML, Anderson WHK et al. Lipid-altering effects of different formulations of hydroxypropylmethylcellulose. J Clin Lipidol. 2009; 3: 159-66.
6. Maki KC, Carson ML, Miller MP et al. Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia. Eur J Clin Nutr. 2009; 63: 1001-7.
7. Maki KC, Davidson MH, Malik KC, Albrecht HH, O'Mullane J, Daggy BP. Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose. Am J Cardiol. 1999; 84: 1198-203.
8. Maki KC, Davidson MH, Torri S et al. High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men. J Nutr. 2000; 130: 1705-10.
9. Hong YJ, Turowski M, Lin JT, Yokoyama WH. Simultaneous characterization of bile acid, sterols, and determination of acylglycerides in feces from soluble cellulose-fed hamsters using HPLC with evaporative light-scattering detection and APCI-MS. J Agric Food Chem. 2007; 55: 9750-7.
10. Bartley GE, Yokoyama W, Young SA et al. Hypocholesterolemic effects of hydroxypropyl methylcellulose are mediated by altered gene expression in hepatic bile and cholesterol pathways of male hamsters. J Nutr. 2010; 140: 1255-60.
11. Yokoyama WH, Shao Q. Soluble fibers prevent insulin resistance in hamsters fed high saturated fat diets. Cereal Foods World. 2006; 51: 16-8.
12. Gallaher DD, Freiburger L, inventors. Regents of the University of Minnesota, assignee. Methods to reduce body fat. US patent no. 6899892. 31 May 2005.
13. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced Type II diabetes in C57BL/6J mice. Diabetes. 1988; 37: 1163-7.
14. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004; 109: 433-8.
15. Collins S, Martin TL, Surwit RS, Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav. 2004; 81: 243-8.
16. Rebuffé-Scrive M, Surwit R, Feinglos M, Kuhn C, Rodin J. Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. Metabolism. 1993; 42: 1405-9.
17. Díaz MB, Eiden S, Daniel C, Steinbrück A, Schmidt I. Effects of periodic intake of a high-caloric diet on body mass and leptin resistance. Physiol Behav. 2006; 88: 191-200.
18. Samuelsson A-M, Matthews PA, Argenton M et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: A novel murine model of developmental programming. Hypertension. 2008; 51: 383-92.
19. Neyrinck AM, Bindels LB, De Backer F, Pachikian BD, Cani PD, Delzenne NM. Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int Immunopharmacol. 2009; 9: 767-73.
20. Institute of Laboratory Animal Resources (ILAR), National Research Council. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington DC, 2006.
21. American Oil Chemists' Society (AOCS). Preparation of Methyl Esters of Long-chain Fatty Acids From Sampling and Analysis of Commercial Fats and Oils. Official Method. AOCS, Champaign, 1997.
22. Hung SC, Bartley G, Young SA et al. Dietary fiber improves lipid homeostasis and modulates adipocytokines in hamsters. J Diabetes. 2009; 1: 194-206.
23. Gallaher DD, Hassel CA, Lee KJ, Gallaher CM. Viscosity and fermentability as attributes of dietary fiber responsible for the hypocholesterolemic effect in hamsters. J Nutr. 1993; 123: 244-52.
24. Ahrén B, Månsson S, Gingerich RL, Havel PJ. Regulation of plasma leptin in mice: Influence of age, high-fat diet, and fasting. Am J Physiol. 1997; 273: R113-20.
25. Surwit RS, Petro AE, Parekh P, Vollins S. Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice. Diabetes. 1997; 46: 1516-20.
26. Unger RH. Lipotoxic diseases. Annu Rev Med. 2002; 53: 319-33.
27. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: Effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996; 81: 4406-13.
28. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996; 271: 10 697-703.
29. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in Type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000; 20: 1595-9.
30. Bonnard C, Durand A, Vidal H, Rieusset J. Changes in adiponectin, its receptors and AMPK activity in tissues of diet-induced diabetic mice. Diabetes Metab. 2008; 34: 52-61.
31. Winzell MS, Nogueiras R, Dieguez C, Ahrén B. Dual action of adiponectin on insulin secretion in insulin-resistant mice. Biochem Biophys Res Commun. 2004; 321: 154-60.
32. Kobayashi M, Ikegami H, Fujisawa T et al. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes. 2007; 56: 239-47.
33. Pajvani U, Hawkins M, Combs TP et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004; 279: 12 152-162.